Clinical Trial Update: SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating short-course radiotherapy plus chemotherapy with Iparomlimab and Tuvonralimab for locally advanced rectal cancer, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Locally Advanced Rectal Cancer (LARC) | Phase 2 | Status: RECRUITING